Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients.
about
Conventional, molecular methods and biomarkers molecules in detection of septicemiaGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveMitochondrial Complex I Is a Global Regulator of Secondary Metabolism, Virulence and Azole Sensitivity in FungiThe era of molecular and other non-culture-based methods in diagnosis of sepsisAspergillus and Fusarium corneal infections are regulated by Th17 cells and IL-17-producing neutrophils.Vitamin D deficiency causes defective resistance to Aspergillus fumigatus in mice via aggravated and sustained inflammation.Dectin-1: a role in antifungal defense and consequences of genetic polymorphisms in humans.Analysis of performance of a PCR-based assay to detect DNA of Aspergillus fumigatus in whole blood and serum: a comparative study with clinical samplesFungal colonization of the respiratory tract in allogeneic and autologous hematopoietic stem cell transplant recipients: a study of 573 transplanted patients.Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method.Multicenter comparison of serum and whole-blood specimens for detection of Aspergillus DNA in high-risk hematological patients.Chlorine gas exposure increases susceptibility to invasive lung fungal infection.Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillanceAntibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan.Posaconazole in the management of refractory invasive fungal infections.Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?Pinpointing prognostic indicators of fungal infections in transplant patients.The prevalence of antifungal agents administration in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective study.Antifungal drug resistance: do molecular methods provide a way forward?Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study.Invasive fungal infections in the ICU: how to approach, how to treat.Eosinophil deficiency compromises lung defense against Aspergillus fumigatus.Neutrophils produce interleukin 17A (IL-17A) in a dectin-1- and IL-23-dependent manner during invasive fungal infection.Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection.Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections.Invasive fungal infection in patients with hematologic disorders in a Brazilian tertiary care hospital.Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantation.Anti-Aspergillus immunoglobulin-G testing in serum of hematopoietic stem cell transplant recipients.Decreased levels of Th17 cells are associated with invasion fungal infections after allogeneic hematopoietic stem cell transplantation.Use of FDG PET/CT for investigation of febrile neutropenia: evaluation in high-risk cancer patients.Broad-Spectrum Molecular Detection of Fungal Nucleic Acids by PCR-Based Amplification Techniques.Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution.Could Histoplasma capsulatum Be Related to Healthcare-Associated Infections?Wild-type MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).Emerging fungal infections in solid organ transplantation.Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatusImmune responses of human immature dendritic cells can be modulated by the recombinant Aspergillus fumigatus antigen Aspf1.Graphium basitruncatum fungemia in an immunosuppressed child post stem-cell transplantation.Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT.
P2860
Q26799362-F6E64885-EB8A-47C3-8419-02C45A33F48BQ28388806-EAA08CE7-C8F9-459B-BAF1-25FB0A5F3D01Q28552733-B3C69019-3222-4CA9-8A9C-CAF9AEBC0B90Q33591270-231EC15E-40CB-4411-B383-431768E854F0Q33607420-911F75EF-2F5C-4DDD-99EE-A8AAF8EFF206Q33754335-AF4F6997-6803-426C-B491-8C83B4344BCAQ34520982-4E9C7272-C9FB-43D4-A6CA-0612C3B84252Q35273787-A2B3D23C-6C7D-4370-81B8-164B19E2F2A5Q35579273-3FED885C-1B2D-47B4-BB3E-A067F9AC2CE2Q36158263-5A9E0C3C-B312-4B83-A581-B02244ED4357Q36826645-B0E7AAA6-91CA-4A06-887E-F10DAF3C882AQ36923913-8511F46D-7974-4ADD-8675-1536D9D12906Q36957891-CAB41BC6-5241-4A9C-9A1E-932FDFACB1F9Q36994288-A6B43972-2958-4B3F-91DA-2E92BD8E4FA9Q37052755-8D265851-5B8A-4820-9F18-6BA6A9A056A3Q37335747-5A368CFB-DF76-4828-9996-27F56358DEB1Q37389541-1E25D5AE-31CF-4B02-98ED-7DB7F851AC84Q37552737-C578D41D-111A-4344-BCF1-8C7499F1D2DEQ37554059-A931A47E-C415-4DCB-AE55-96392B4C3C14Q37711537-E436B42B-84C4-4BF9-9746-B560CBBBD92AQ38180287-19CF3DD8-09EB-455C-9F7D-20BE750A72C3Q38328091-632B4B9C-882C-471F-BE8D-9B6C570D6B48Q38629718-FB5EE8E1-E089-46AE-BB66-00DE3E3DEA23Q38688900-F62ABEC9-2917-400A-AD57-8A58AE103241Q38726054-1B9A465E-1351-496B-8AA9-48A685914FE6Q38880522-47245AFE-7CDB-4926-B6B0-199D3985AADFQ38887496-0D4A8552-A160-470B-9441-C2090F46D5ACQ39196770-2428264C-4E79-402D-84EB-A78BFA135D5FQ39902358-7E519DAA-0430-4476-9FB5-14757700C00EQ40062807-A9A43DF8-9AE3-40B4-91BA-46850FB209B8Q40287041-214EE501-ED6D-493C-9078-C7641E27668EQ40454833-ADE90585-0A23-4895-BEB3-532F8D8E99AAQ40475150-44F1FE73-8A68-421A-9B09-94B4EC6FF7D5Q41142605-D3F2EC76-61B7-477A-AA75-90DF74448B58Q42116260-A434A21B-4714-4862-8434-28BFC63C611BQ42272283-ECD1F1EC-EA59-4C74-B22D-845493279FB2Q42323203-D868FF40-8C0A-41D5-B9E3-C6B76A07DA89Q42576385-836640D1-27B6-4D40-B8DC-A3742D22D198Q42838532-A7050A0A-ED79-4AA8-8262-1C3454E332FAQ43267400-39BE697B-9A4F-443B-8063-C2D81F011BA8
P2860
Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Risks, diagnosis and outcomes ...... em cell transplant recipients.
@en
type
label
Risks, diagnosis and outcomes ...... em cell transplant recipients.
@en
prefLabel
Risks, diagnosis and outcomes ...... em cell transplant recipients.
@en
P2860
P1476
Risks, diagnosis and outcomes ...... em cell transplant recipients.
@en
P2093
Kieren A Marr
Penelope D Barnes
P2860
P304
P356
10.1111/J.1365-2141.2007.06812.X
P407
P577
2007-11-01T00:00:00Z